High performance of targeted next generation sequencing on variance detection in clinical tumor specimens in comparison with current conventional methods

Abstract

DNA from cancer cell lines is better than standard DNA as a reference to establish basic parameters for targeted NGS. Comparison of the conventional methods using a large cohort of patient samples confirmed the high preformance of targeted NGS on detecting DNA alterations.